Cargando…
Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency
Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disorder caused by mutations in the gene-encoding acid sphingomyelinase (ASM). ASMD impacts peripheral organs in all patients, including the liver and spleen. The infantile and chronic neurovisceral forms of the disease also lead to neur...
Autores principales: | Gaudioso, Ángel, Moreno-Huguet, Pilar, Casas, Josefina, Schuchman, Edward H., Ledesma, María Dolores |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253472/ https://www.ncbi.nlm.nih.gov/pubmed/37298714 http://dx.doi.org/10.3390/ijms24119756 |
Ejemplares similares
-
Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency
por: Gaudioso, Ángel, et al.
Publicado: (2023) -
Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling
por: Bartoll, Adrián, et al.
Publicado: (2020) -
Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)
por: Wasserstein, Melissa, et al.
Publicado: (2018) -
Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency
por: McGovern, Margaret M., et al.
Publicado: (2017) -
Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase
por: He, Xingxuan, et al.
Publicado: (2023)